Language Select
Varian Logo

Neueste Nachrichten

Januar 14, 2019
With nearly 1,300 Chinese radiation oncology professionals in attendance and an additional 8,000 users watching via a live webcast, Varian (NYSE: VAR) recently held its 2019 China Users Meeting in... Read more
Dezember 24, 2018
Varian (NYSE: VAR) today announced it received notification from the United States Trade Representative (USTR) that its exclusion request for Halcyon™ radiotherapy systems for cancer treatments,... Read more
Dezember 19, 2018
Varian (NYSE: VAR) today announced that Dow Wilson, chief executive officer, and Chris Toth, president of Oncology Systems, will present at the J.P. Morgan Healthcare Conference in San Francisco,... Read more

Neueste Blog-Posts

Dez. 13, 2018 | Centerline
ARIA® for Medical Oncology was recently rolled out across Northern Ireland. As a result, every cancer patient in a province of nearly two million people now has a clinical record within the ARIA... Read more
Dez. 07, 2018 | Centerline
The radiation oncology department at Loyola University Medical Center is using ARIA® Connect to bridge the gap between ARIA and the Epic® electronic health record used by the larger medical center.... Read more
Dez. 06, 2018 | Centerline
83-year-old New Jersey Resident Among the First in the U.S. to Receive a Calypso-Guided Treatment for Cancer of the Lung... Read more

Erhalten Sie Nachrichtenmitteilungen per E-Mail
Jetzt abonnieren

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com